V020-6533 Screening compound: 10-[4-(BENZENESULFONYL)-3-METHYLPIPERAZIN-1-YL]-14-METHOXY-2-OXA-9-AZATRICYCLO[9.4.0.0^(3,8)]PENTADECA-1(11),3,5,7,9,12,14-HEPTAENE

V020-6533 Screening compound: 10-[4-(BENZENESULFONYL)-3-METHYLPIPERAZIN-1-YL]-14-METHOXY-2-OXA-9-AZATRICYCLO[9.4.0.0^(3,8)]PENTADECA-1(11),3,5,7,9,12,14-HEPTAENE
V020-6533 Screening compound: 10-[4-(BENZENESULFONYL)-3-METHYLPIPERAZIN-1-YL]-14-METHOXY-2-OXA-9-AZATRICYCLO[9.4.0.0^(3,8)]PENTADECA-1(11),3,5,7,9,12,14-HEPTAENE alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-6533
10-[4-(BENZENESULFONYL)-3-METHYLPIPERAZIN-1-YL]-14-METHOXY-2-OXA-9-AZATRICYCLO[9.4.0.0^(3,8)]PENTADECA-1(11),3,5,7,9,12,14-HEPTAENE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-6533

Molecular Formula

C25H25N3O4S (C25 H25 N3 O4 S)

Compound Name

10-[4-(BENZENESULFONYL)-3-METHYLPIPERAZIN-1-YL]-14-METHOXY-2-OXA-9-AZATRICYCLO[9.4.0.0^(3,8)]PENTADECA-1(11),3,5,7,9,12,14-HEPTAENE

IUPAC name

10-[4-(benzenesulfonyl)-3-methylpiperazin-1-yl]-14-methoxy-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)35791214-heptaene

SMILES

CC(CN(CC1)C2=Nc(cccc3)c3Oc3c2ccc(OC)c3)N1S(c1ccccc1)(=O)=O

InChI

InChI=1S/C25H25N3O4S/c1-18-17-27(14-15-28(18)33(29,30)20-8-4-3-5-9-20)25-21-13-12-19(31-2)16-24(21)32-23-11-7-6-10-22(23)26-25/h3-13,16,18H,14-15,17H2,1-2H3

InChI Key

ODKBSNUVUMSALD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14284236

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

463.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.098

Distribution Coefficient, logD

3.572

Water Solubility, LogSw

-4.35

Polar Surface Area

57.320

Acid Dissociation Constant (pKa)

25.89

Base Dissociation Constant (pKb)

7.77

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.00

V020-6533 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Cardiovascular Library (22201 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cardiovascular
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V020-6533 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-6533?
Check Price and Availability of V020-6533, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-6533 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-6533
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-6533
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-6533 available by request